Clinical Biomarkers and Biotechnology in Fertile Window

Journal Title: Interventions in Gynaecology and Women’s Healthcare - Year 2018, Vol 2, Issue 2

Abstract

The recognition of fertility is increasingly important in prestigious scientific groups and in renowned international schools [1]. In this sense, we have tried to objectify the changes observed in the evolutionary process in the fertile window produced by the effect of estrogen and progesterone. Among the most relevant schools with this methodology are some authors such as; Hilgers[2], Stanfort[3], Scarpa [4], Aldecreutz[5], Ecochard[6] etc. These relevant contributions are based on the same clinical principle of fertile clinical window, which are based on the changes of cervical secretion pattern throughout the menstrual cycle. The fundamentals of this interest are justified in the perspectives that the application of the accumulated research of the basic principles of ovarian physiology pose. The pulsatile release of gonadotropinreleasing hormone (GNRH) stimulates the production of luteinizing hormone (LH) and follicle-stimulating hormone (FSH) in the anterior pituitary gland. These two hormones are responsible for stimulating the secretion of estrogen and progesterone at the level of the ovary, which justifies the physicochemical changes that occur in the cervical secretion [7]. Another aspect derived from clinical research in this field is the biotechnological implications derived from the biophysical properties of cervical secretion in the recognition of fertility. In this same line, the number of companies recognized by the scientific community in the development of devices related to the recognition of fertile time has increased. Among them: Swiss Precision Diagnostics (SPD) GmbH (Switzerland), Church & Dwight Co., Inc. (USA), Prestige Brands Holdings, Inc. (USA), Fairhaven Health, LLC (USA) ,HiLin Life of the product, Inc. (USA), Fertility Focus Limited (UK), and Geratherm Medical AG (Germany). According to a report recently published by Markets and Markets, the global market for devices, or so-called fertility tests, during the projected period of 2015 to 2020 is estimated to reach USD 151.0 million. Additionally, investment in this type of technology is forecast to grow at a compound annual rate of 7.5% during the 2015-2020 forecast period to reach USD 216.8 million in 2020 (Figure 1). Since 2015, to mention one of the recently studied intervals in time, the region between the United States and Canada had one of the largest shares in the global market of devices and tests for the recognition of fertility. The expectations in this respect are evident in the results obtained in devices developed to diagnose fertility tests in the mentioned regions, and it is expected that in Asia and the Pacific a greater annual growth will be reached (Figure 2). Another fact that stands out is the interest associated with the greater number of patent applications in devices for the recognition of fertility, with China leading the market, followed by the US office, as observed in the time interval included between 2007-2010 (Figure 3). Among the main applicants are Aronne Louis J with 3.8% of the applications, Kosasky; Harold J., President and Fellows of Harvard College, and The Regents of the University of California each with 1.4% of the applications.

Authors and Affiliations

Murcia Lora José María

Keywords

Related Articles

Features of Rheumatic Disease Management while Pregnancy

Rheumatism is a systemic inflammatory disease of connective tissue and joints with a predominantly affected heart. Children and young people are ill mostly: women are 3 times more likely than men. Therefore, the problem...

Laughter Therapy Decreases Depression Among in Senior Citizens Residing in Old Age Homes

Aging is an inevitable process and many factors like genes, lifestyles, diet and environment determine longevity. As humans go older, physical conditions decline which leads to many illnesses. Depression constitutes the...

Major Issues Related to Women Health, Social, Cultural and Economic Development

Present article sketches out major issues related to health, social, cultural, and economic wellbeing of the women. Most prevailing problems are related to malnutrition, sociality, sanitation, shelter, education, and liv...

Probiotics Intervention in Woman Health: Unexpected Acquaintance

There is growing interest in health promoting benefits of probiotics as bio therapeutic agents. Probioticsare used to treat recurrent urinary tract infections, diabetes, diarrhoea, vulvovaginal candidiasis and bacterial...

Pethidine Infiltration in Intra Fascial Layer After Abdominal Hysterectomy

Introduction: multimodal analgesia regimen has a cornerstone component involving local wound infiltration with analgesic agents to manage and enhance post-operative pain to increase patient satisfaction. Aim: assessment...

Download PDF file
  • EP ID EP573233
  • DOI 10.32474/IGWHC.2018.02.000135
  • Views 70
  • Downloads 0

How To Cite

Murcia Lora José María (2018). Clinical Biomarkers and Biotechnology in Fertile Window. Interventions in Gynaecology and Women’s Healthcare, 2(2), 146-150. https://europub.co.uk/articles/-A-573233